Chepelev Iouri, Wei Gang, Tang Qingsong, Zhao Keji
Laboratory of Molecular Immunology, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Nucleic Acids Res. 2009 Sep;37(16):e106. doi: 10.1093/nar/gkp507. Epub 2009 Jun 15.
Whole-genome resequencing is still a costly method to detect genetic mutations that lead to altered forms of proteins and may be associated with disease development. Since the majority of disease-related single nucleotide variations (SNVs) are found in protein-coding regions, we propose to identify SNVs in expressed exons of the human genome using the recently developed RNA-Seq technique. We identify 12 176 and 10 621 SNVs, respectively, in Jurkat T cells and CD4(+) T cells from a healthy donor. Interestingly, our data show that one copy of the TAL-1 proto-oncogene has a point mutation in 3' UTR and only the mutant allele is expressed in Jurkat cells. We provide a comprehensive dataset for further understanding the cancer biology of Jurkat cells. Our results indicate that this is a cost-effective and efficient strategy to systematically identify SNVs in the expressed regions of the human genome.
全基因组重测序仍然是一种成本高昂的方法,用于检测导致蛋白质形式改变且可能与疾病发展相关的基因突变。由于大多数与疾病相关的单核苷酸变异(SNV)存在于蛋白质编码区域,我们建议使用最近开发的RNA测序(RNA-Seq)技术来鉴定人类基因组中表达外显子的SNV。我们分别在来自健康供体的Jurkat T细胞和CD4(+) T细胞中鉴定出12176个和10621个SNV。有趣的是,我们的数据显示,原癌基因TAL-1的一个拷贝在3'非翻译区(UTR)有一个点突变,并且只有突变等位基因在Jurkat细胞中表达。我们提供了一个全面的数据集,以进一步了解Jurkat细胞的癌症生物学特性。我们的结果表明,这是一种经济高效的策略,可用于系统地鉴定人类基因组表达区域中的SNV。